Volta Labs and Hartwig Medical Foundation have announced their multi-year collaboration aimed at developing a sample processing platform for the most common cancer diagnostic sequencing applications.

"We began collaborating with the Volta Labs team two years ago, and we believe the Callisto Sample Prep System represents the future of sample preparation in diagnostic labs. Callisto already delivers an excellent hybrid capture workflow, and we are now working together to enable whole genome sequencing on various DNA sources as well as new capabilities across multiple emerging short-read sequencing platforms. Once development is complete, we plan to integrate the Callisto platform into clinical studies and adopt it for routine use in our clinical accredited testing workflows", said Ewart de Bruijn, Innovation Lead at Hartwig Medical Foundation.

‍

‍

The collaboration between Hartwig and Volta will include advancing the next generation of sample prep “apps” spanning across whole genome sequencing, targeted sequencing, ctDNA, and RNA profiling across multiple sequencing technologies.

‍

About Hartwig:

Hartwig Medical Foundation is a global leader in genomics-driven oncology research and clinical care. They improve cancer patient care by generating, analyzing, and sharing high-quality genomic and clinical data, enhancing diagnostics, enabling personalized treatments, and supporting the development of more effective future therapies.